244 related articles for article (PubMed ID: 34527736)
1. The Challenge of Using an Antigen Test as a Screening Tool for SARS-CoV-2 Infection in an Emergency Department: Experience of a Tertiary Care Hospital in Southern Italy.
Loconsole D; Centrone F; Morcavallo C; Campanella S; Sallustio A; Casulli D; Accogli M; Chironna M
Biomed Res Int; 2021; 2021():3893733. PubMed ID: 34527736
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Detection Tests Using Oral, Anterior Nasal, and Nasopharyngeal Swabs: a Diagnostic Accuracy Study.
Wölfl-Duchek M; Bergmann F; Jorda A; Weber M; Müller M; Seitz T; Zoufaly A; Strassl R; Zeitlinger M; Herkner H; Schnidar H; Anderle K; Derhaschnig U
Microbiol Spectr; 2022 Feb; 10(1):e0202921. PubMed ID: 35107327
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Lumipulse® G SARS-CoV-2 antigen assay automated test for detecting SARS-CoV-2 nucleocapsid protein (NP) in nasopharyngeal swabs for community and population screening.
Gili A; Paggi R; Russo C; Cenci E; Pietrella D; Graziani A; Stracci F; Mencacci A
Int J Infect Dis; 2021 Apr; 105():391-396. PubMed ID: 33647511
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of the Elecsys SARS-CoV-2 antigen assay in the clinical routine of a tertiary care hospital: Preliminary results from a single-center evaluation.
Mueller T; Kompatscher J; La Guardia M
J Clin Lab Anal; 2021 Aug; 35(8):e23906. PubMed ID: 34251047
[TBL] [Abstract][Full Text] [Related]
5. On-field evaluation of a ultra-rapid fluorescence immunoassay as a frontline test for SARS-CoV-2 diagnostic.
Orsi A; Pennati BM; Bruzzone B; Ricucci V; Ferone D; Barbera P; Arboscello E; Dentone C; Icardi G
J Virol Methods; 2021 Sep; 295():114201. PubMed ID: 34058287
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 antigen rapid immunoassay for diagnosis of COVID-19 in the emergency department.
Möckel M; Corman VM; Stegemann MS; Hofmann J; Stein A; Jones TC; Gastmeier P; Seybold J; Offermann R; Bachmann U; Lindner T; Bauer W; Drosten C; Rosen A; Somasundaram R
Biomarkers; 2021 May; 26(3):213-220. PubMed ID: 33455451
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of CLINITEST® Rapid Covid-19 + Influenza antigen test in a cohort of symptomatic patients in an emergency department.
Maldonado-Barrueco A; Gutiérrez-Arroyo A; Bloise I; de Ceano-Vivas M; Rivera-Nuñez A; Santos-Olmos RT; Vega DM; García-Rodríguez J;
Eur J Clin Microbiol Infect Dis; 2024 May; 43(5):853-861. PubMed ID: 38421466
[TBL] [Abstract][Full Text] [Related]
8. Clinical assessment of the Roche SARS-CoV-2 rapid antigen test.
Salvagno GL; Gianfilippi G; Bragantini D; Henry BM; Lippi G
Diagnosis (Berl); 2021 Aug; 8(3):322-326. PubMed ID: 33554511
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS® SARS-CoV-2 Antigen Test.
Matsuzaki N; Orihara Y; Kodana M; Kitagawa Y; Matsuoka M; Kawamura R; Takeuchi S; Imai K; Tarumoto N; Maesaki S; Maeda T
J Med Virol; 2021 Dec; 93(12):6778-6781. PubMed ID: 34170555
[TBL] [Abstract][Full Text] [Related]
10. Utility of Antigen-Based Rapid Diagnostic Test for Detection of SARS-CoV-2 Virus in Routine Hospital Settings.
Thakur P; Saxena S; Manchanda V; Rana N; Goel R; Arora R
Lab Med; 2021 Nov; 52(6):e154-e158. PubMed ID: 33928384
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the field performance of multiple SARS-Cov-2 antigen rapid tests using nasopharyngeal swab samples.
Nóra M; Déri D; Veres DS; Kis Z; Barcsay E; Pályi B
PLoS One; 2022; 17(2):e0262399. PubMed ID: 35157700
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of 1308 nasopharyngeal swabs from 1033 patients using the LUMIPULSE SARS-CoV-2 antigen test: Comparison with RT-qPCR.
Hirotsu Y; Maejima M; Shibusawa M; Amemiya K; Nagakubo Y; Hosaka K; Sueki H; Hayakawa M; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Omata M
Int J Infect Dis; 2021 Apr; 105():7-14. PubMed ID: 33556612
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Performance of an Antigen Test with RT-PCR for the Detection of SARS-CoV-2 in a Hospital Setting - Los Angeles County, California, June-August 2020.
Brihn A; Chang J; OYong K; Balter S; Terashita D; Rubin Z; Yeganeh N
MMWR Morb Mortal Wkly Rep; 2021 May; 70(19):702-706. PubMed ID: 33983916
[TBL] [Abstract][Full Text] [Related]
14. Frontline Screening for SARS-CoV-2 Infection at Emergency Department Admission by Third Generation Rapid Antigen Test: Can We Spare RT-qPCR?
Cento V; Renica S; Matarazzo E; Antonello M; Colagrossi L; Di Ruscio F; Pani A; Fanti D; Vismara C; Puoti M; Scaglione F; Perno CF; Alteri C; On Behalf Of The S Co Va Study Group
Viruses; 2021 May; 13(5):. PubMed ID: 34062916
[TBL] [Abstract][Full Text] [Related]
15. Time scale performance of rapid antigen testing for SARS-CoV-2: Evaluation of 10 rapid antigen assays.
Abusrewil Z; Alhudiri IM; Kaal HH; El Meshri SE; Ebrahim FO; Dalyoum T; Efrefer AA; Ibrahim K; Elfghi MB; Abusrewil S; Elzagheid A
J Med Virol; 2021 Dec; 93(12):6512-6518. PubMed ID: 34241912
[TBL] [Abstract][Full Text] [Related]
16. Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres.
Albert E; Torres I; Bueno F; Huntley D; Molla E; Fernández-Fuentes MÁ; Martínez M; Poujois S; Forqué L; Valdivia A; Solano de la Asunción C; Ferrer J; Colomina J; Navarro D
Clin Microbiol Infect; 2021 Mar; 27(3):472.e7-472.e10. PubMed ID: 33189872
[TBL] [Abstract][Full Text] [Related]
17. Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms.
Linares M; Pérez-Tanoira R; Carrero A; Romanyk J; Pérez-García F; Gómez-Herruz P; Arroyo T; Cuadros J
J Clin Virol; 2020 Dec; 133():104659. PubMed ID: 33160179
[TBL] [Abstract][Full Text] [Related]
18. Feasibility and Effectiveness Assessment of SARS-CoV-2 Antigenic Tests in Mass Screening of a Pediatric Population and Correlation with the Kinetics of Viral Loads.
Lanari M; Biserni GB; Pavoni M; Borgatti EC; Leone M; Corsini I; Lazzarotto T
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696501
[TBL] [Abstract][Full Text] [Related]
19. A novel strategy for SARS-CoV-2 mass screening with quantitative antigen testing of saliva: a diagnostic accuracy study.
Yokota I; Shane PY; Okada K; Unoki Y; Yang Y; Iwasaki S; Fujisawa S; Nishida M; Teshima T
Lancet Microbe; 2021 Aug; 2(8):e397-e404. PubMed ID: 34031649
[TBL] [Abstract][Full Text] [Related]
20. High performance of a novel antigen detection test on nasopharyngeal specimens for diagnosing SARS-CoV-2 infection.
Courtellemont L; Guinard J; Guillaume C; Giaché S; Rzepecki V; Seve A; Gubavu C; Baud K; Le Helloco C; Cassuto GN; Pialoux G; Hocqueloux L; Prazuck T
J Med Virol; 2021 May; 93(5):3152-3157. PubMed ID: 33615487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
